FoxG1 as a Potential Therapeutic Target for Alzheimer’s Disease: Modulating NLRP3 Inflammasome via AMPK/mTOR Autophagy Pathway. The gene discussed is MTOR; the disease is early-onset autosomal dominant Alzheimer disease.